Solutions
Accelerate adoption of new therapies and advance patient care
Leverage real-world data, powerful analytics, and the Truveta Language Model to support therapy development and access, care quality improvement, and public health.
How we can help
Safety
Fulfill post-market regulartory requirements and assess long-term product safety more efficiently with real-time data.
Truveta enables life sciences companies to:
- Meet regulatory evidence standards faster and at lower cost by eliminating the need for expensive and long-running registries
- Quickly assess the validity of potential safety signals with real-time data
- Conduct studies assessing the long-term, real-world safety of different treatments with access to complete medical records, including notes and images
Assessing the safety of novel interventions
Comparative bleeding incidence 7 days post-procedure for pulmonary embolism interventions
HEOR
Evaluate clinical- and cost-effectiveness to differentiate products using real-world data from 30 health systems.
Truveta enables life sciences companies to:
- Assess the clinical- and cost-effectiveness of therapies to inform access and reimbursement decisions
- Generate scientific evidence on comparative effectiveness and long-term outcomes to connect the right patients to the right therapies
- Analyze real-world treatment pathways and healthcare resource utilization patterns to inform access and engagement programs
Comparing real-world treatment outcomes
Hazard of cardiovascular events associated with SGLT2i vs metformin
Public health
Monitor disease trends and identify disparities in healthcare access and outcomes with EHR data from 120M+ patients across the US
Truveta enables government and academic research organizations to:
- Monitor disease trends and vaccine safety with daily-updated data
- Study maternal and child health with access to more than 1 million mother-child pairs
- Analyze the impact of SDOH variables on healthcare access and outcomes
- Gauge the impact of policies on health outcomes, healthcare utilization, costs, and population health with complete EHR data linked to SDOH, mortality, and claims data
Respiratory virus-associated hospitalizations (from monitoring report)
Rate of weekly respiratory virus-associated hospitalizations compared to all hospitalizations since October 2019
Clinical trials
Validate trial design and supplement trial data with real-world arms.
Truveta enables life sciences companies to:
- Build and analyze precise populations with complete data for 120M+ patients
- De-risk clinical programs with dynamic, real-time analyticsÂ
- Generate evidence for real-world control arms using regulatory-grade data
Testing I/E criteria to de-risk clinical programs
Sample heart failure population with inclusion/exclusion criteria applied
Care quality
Real-time dashboard showing TAVR volumes, access by cohort, and adverse events Monitor patient outcomes and benchmark to real-time, nationally representative EHR data.
Truveta enables healthcare organizations to:
- Deliver more equitable, high-quality care by identifying disparities and gaps in care
- Guide evidence-based decisions by linking treatment patterns to outcomes
- Assess variations in care quality to support value-based care programs
Tracking procedure utilization and outcomes over time
Real-time dashboard showing TAVR volumes, access by cohort, and adverse events
Market access
Monitor and ensure patient access to therapies using real-time EHR data.Â
Truveta enables life sciences companies to:
- Assess product utilization and market share trends
- Generate compelling evidence of real-world effectiveness and economic value to inform coverage and reimbursement decisions
- Monitor and remediate the impact of potential supply chain shortagesÂ
Assessing the impact of drug shortages
Rate of amphetamine/dextroamphetamine prescription fills per eligible population, stratified by age
Research and development
Train AI models for discovery and product enhancement with complete and representative EHR data.Â
Truveta enables life sciences companies to:
- Identify patient subgroups most likely to respond to a therapy or experience specific medical events
- Discover product enhancement or innovation opportunities using AI trained on medical records
Exploring the association between heart failure and medication use
Population clustering to facilitate drug discovery
How we can help
Safety
HEOR
Public health
Clinical trials
Care quality
Market access
Research & development
Safety
Fulfill post-market regulatory requirements and assess long-term product safety more efficiently with real-time data.
Truveta enables life sciences companies to:
Quickly assess the validity of potential safety signals with real-time data
Conduct studies assessing the long-term, real-world safety of different treatments with access to complete medical records data, including notes and images
Assessing the safety of novel interventions
Comparative bleeding incidence 7 days post-procedure for pulmonary embolism interventions
HEOR
Evaluate clinical- and cost-effectiveness to differentiate products using real-world data from 30 health systems.
Truveta enables life sciences companies to:
Assess the clinical- and cost-effectiveness of therapies to inform access and reimbursement decisions
Generate scientific evidence on comparative effectiveness and long-term outcomes to connect the right patients to the right therapies
Analyze real-world treatment pathways and healthcare resource utilization patterns to inform access and engagement programs
Hazard of cardiovascular events associated with SGLT2i vs metformin
Public health
Monitor disease trends and identify disparities in healthcare access and outcomes with EHR data from 120M patients across the US.
Truveta enables government and academic research organizations to:
Monitor disease trends and vaccine safety with daily-updated data
Study maternal and child health with access to more than 1 million mother-child pairs
Analyze the impact of SDOH variables on healthcare access and outcomes
Gauge the impact of policies on health outcomes, healthcare utilization, costs, and population health with complete EHR data linked to SDOH, mortality, and claims data
Rate of weekly respiratory virus-associated hospitalizations compared to all hospitalizations since October 2019
Clinical trials
Validate trial design and supplement trial data with real-world arms.
Truveta enables life sciences companies to:
Build and analyze precise populations with complete data for 120M+ patients
Generate evidence for real-world control arms using regulatory-grade data
Testing I/E criteria to de-risk clinical programs
Sample heart failure population with inclusion/exclusion criteria applied
Care quality
Monitor patient outcomes and benchmark to real-time, nationally representative EHR data.
Truveta enables healthcare organizations to:
Deliver more equitable, high-quality care by identifying disparities and gaps in care
Guide evidence-based decisions by linking treatment patterns to outcomes
Assess variations in care quality to support value-based care programs
Real-time dashboard showing TAVR volumes, access by cohort, and adverse events
Market access
Monitor and ensure patient access to therapies using real-time EHR data.
Truveta enables life sciences companies to:
Assess product utilization and market share trends
Generate compelling evidence of real-world effectiveness and economic value to inform coverage and reimbursement decisions
Monitor and remediate the impact of potential supply chain shortages
Assessing the impact of drug shortages
Rate of amphetamine/dextroamphetamine prescription fills per eligible population, stratified by age
Research and development
Train AI models for discovery and product enhancement with complete and representative EHR data.
Truveta enables life sciences companies to:
Identify patient subgroups most likely to respond to a therapy or experience specific medical events
Population clustering to facilitate drug discovery
Why Truveta
Regulatory-grade EHR data
Truveta offers complete, timely, and clean EHR data linked with SDOH, mortality, and claims data for more than 120 million patients representing the full diversity of the US.
Powerful analytics
Truveta Studio provides immediate access to Truveta Data, powerful analytics and AI, and evidence fit for regulatory submission.
Trusted health system relationships
Truveta members share in our commitment to data quality, adhering to rigorous standards for representativeness, completeness, timeliness, and cleanliness from the point of ingestion.
Trusted by leading life science, government, academic, health system, and research organizations.
